BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wynick C, Britto J, Sawler D, Parker A, Karkhaneh M, Goodyear MD, Sun HL. Validation of the PLASMIC score for predicting ADAMTS13 activity <10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada. Thromb Res 2020;196:335-9. [PMID: 32977133 DOI: 10.1016/j.thromres.2020.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Reeves HM, Maitta RW. Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.05.008] [Reference Citation Analysis]
2 Marins LR, da Rocha Oppermann ML. Thrombotic thrombocytopenic purpura and acquired immunodeficiency syndrome diagnosed in pregnancy: Case report. J Obstet Gynaecol Res 2021;47:1898-902. [PMID: 33719122 DOI: 10.1111/jog.14717] [Reference Citation Analysis]
3 Reddy MS, Newsom N, Sakurai S, Park SY, Reisch J, Sarode R. Performance of the PLASMIC score is improved with a positive score defined as ≥5 and with the inclusion of neurological symptoms. Br J Haematol 2022. [PMID: 35261027 DOI: 10.1111/bjh.18123] [Reference Citation Analysis]
4 Wade AN, Panchmatia R, Calderon P. Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome With Severe Thrombocytopenia and Severe ADAMTS13 Activity Deficiency. Obstet Gynecol 2021;137:873-6. [PMID: 33831917 DOI: 10.1097/AOG.0000000000004345] [Reference Citation Analysis]
5 Nelson D, Kodsi M, Cockrell D, Morgan J, Key N. Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab. J Oncol Pharm Pract 2022;:10781552211073883. [PMID: 35037788 DOI: 10.1177/10781552211073883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Burguet L, Taton B, Prezelin-Reydit M, Rubin S, Picard W, Gruson D, Ryman A, Contin-Bordes C, Coppo P, Combe C, Delmas Y. Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis. J Clin Med 2022;11:648. [PMID: 35160098 DOI: 10.3390/jcm11030648] [Reference Citation Analysis]
7 Zheng XL. The standard of care for immune thrombotic thrombocytopenic purpura today. J Thromb Haemost 2021;19:1864-71. [PMID: 34060225 DOI: 10.1111/jth.15406] [Reference Citation Analysis]
8 Fage N, Orvain C, Henry N, Mellaza C, Beloncle F, Tuffigo M, Geneviève F, Coppo P, Augusto JF, Brilland B. Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome. Kidney International Reports 2021. [DOI: 10.1016/j.ekir.2021.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Hegde R, Ismail R, Vegunta A, Megahed A, Sharma P, Rosovsky M. Atypical posterior reversible encephalopathy syndrome in a case of thrombotic thrombocytopenic purpura with Sjogren's syndrome. Radiol Case Rep 2021;16:1552-6. [PMID: 33981376 DOI: 10.1016/j.radcr.2021.03.035] [Reference Citation Analysis]